Clinical Trials Logo

Filter by:
NCT ID: NCT04899518 Completed - Dry Eye Clinical Trials

ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease

OASIS-1
Start date: May 19, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Study Evaluating the Safety and Efficacy of Two Concentrations (0.4% and 1%) of ALY688 Ophthalmic Solution in Subjects with Dry Eye Disease

NCT ID: NCT04899440 Completed - Gingivitis Clinical Trials

Measuring Efficacy of an Oral-Irrigator After Three Weeks of Use

Start date: June 3, 2021
Phase:
Study type: Interventional

The primary objective of this exploratory study is to evaluate the efficacy of an Oral Irrigator in the reduction of gingivitis compared to a negative control over a 3 week period by using the Modified Gingival Index and the Gingival Bleeding Index. The secondary objective is to evaluate the efficacy of an Oral Irrigator in the reduction of plaque compared to a negative control using the extended Turesky Modified Quigley-Hein Index (TQHPI) after 3 weeks of use.

NCT ID: NCT04899375 Completed - Elbow Tendinopathy Clinical Trials

Effect of Tissue Flossing on Pain,Function and Movement

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The purpose of the current investigation is to examine the effect of tissue-flossing on upper extremity, pain, strength and functional performance in subjects with musculoskeletal-related complaints of pain surrounding the elbow complex

NCT ID: NCT04899245 Completed - COVID-19 Clinical Trials

ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff

Start date: May 4, 2021
Phase: N/A
Study type: Interventional

The Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, is a worldwide pandemic that has resulted in large-scale quarantines in cities, states, and countries throughout the world. SARS-CoV-2 is a respiratory virus that is most commonly spread via contact with infective respiratory droplets and aerosols produced by coughing, sneezing, talking, and singing. Children with medical complexity (CMC), i.e., children with multiple severe chronic conditions, high resource use, severe functional limitations, and substantial family-identified service needs, are a medically vulnerable population for the development of severe COVID-19. Deciding to send CMC to school poses a major dilemma to families wanting to minimize severe COVID-19 risk. School personnel also face risks when CMC attend school. Despite these challenges, achieving in-person school attendance is critical for CMC. Compared to non-CMC, academic and social development for most CMC hinges on being at school. Severe intellectual and developmental disability impairs one's ability to engage with online platforms. Health-promoting services delivered at school, e.g., physical, occupational, and speech therapy, are likely less effective when delivered virtually. Parents of CMC, already disproportionately unemployed due to their child's care needs, experience added employment strain when their child is out of school. The study objective is to increase the safe return to school for CMC by 1) evaluating the feasibility of school-based COVID-19 testing strategies and 2) identifying parent and staff perceptions of testing and school attendance. A related study (ReSET Aim 1a, NCT04895085) will evaluate the same factors in home-based testing strategies in CMC exclusively.

NCT ID: NCT04899167 Completed - Clinical trials for Kidney Transplantation

Noninvasive Evaluation of Renal Allograft Fibrosis by MRI

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to validate an MRI method to detect renal fibrosis in patients after kidney transplantation (KT).

NCT ID: NCT04899115 Completed - Cirrhosis Clinical Trials

VE303 for Treatment of Hepatic Encephalopathy (HE)

Start date: August 6, 2021
Phase: Phase 2
Study type: Interventional

This research is studying the use of a new drug to learn about its safety and efficacy as a treatment for hepatic encephalopathy. Eligible participants will be enrolled and given oral antibiotics followed by 14 days of the study drug (placebo vs.VE303). There will be visits as well as other procedures to collect blood and stool samples, and have tests of your cognition (thinking) for this research study. The hypothesis is that VE303 will safely and effectively improve cognitive function in patients with a history of overt hepatic encephalopathy.

NCT ID: NCT04899089 Completed - Clinical trials for Mild Cognitive Impairment

Cognitive Training in Mild Cognitive Impairment

TRAIN-MCI
Start date: July 28, 2021
Phase: N/A
Study type: Interventional

Older adults (60+ years of age) who meet criteria for mild cognitive impairment and insomnia will be randomly assigned to cognitive training or trivia training and will complete measures of anxiety, sleep, cognition (objective, self-efficacy), and arousal at baseline, and post-intervention. For cognitive training, participants will be provided with login information to access the computerized training, and will complete 8 weeks (45 mins 3x/week) of cognitive training. For trivia training, participants will receive weekly emails that contain trivia assignments that they will complete for 8 weeks (45 mins 3x/week). We will evaluate short-term (i.e., post-training) effects of the two training conditions on subjective anxiety, sleep, arousal, and subjective and objective cognition.

NCT ID: NCT04899050 Completed - Clinical trials for Study the Efficacy of Epidiolex for Typical Absence Seizures

Epidiolex in Typical Absence Seizures

Start date: July 30, 2021
Phase: Phase 4
Study type: Interventional

This is a Pilot study, open-label study consisting of a screening period of up to 4 weeks, a 4-week dose-titration treatment period to dose of up to 20 mg/kg/day BID of CBD (Epidiolex), and a 30 day safety follow-up period following the last dose of study medication.

NCT ID: NCT04898881 Completed - Pain Clinical Trials

Breast Milk vs Sucrose in Relieving Procedural Pain in Preterm Neonates During Blood Draw by Automated Heel Lance

Start date: January 1, 2020
Phase: Phase 4
Study type: Interventional

Skin breaking procedure through an automated heel lancet for blood draws is a common painful procedure in the Neonatal Intensive care unit (NICU). Recurrent pain in preterm neonates is associated with long-term complications. The primary objective of the study is to compare pain scores between two groups (24% sucrose and breast milk) during blood draw using an automated heel lancet in preterm neonates. The investigator conducted a prospective randomized controlled trial in preterm neonates, to compare the pain scores in infants receiving either breast milk or sucrose. Premature Infant pain profile- Revised pain profile is used to assign pain scores. The primary outcome measure is the comparison of pain scores between the two groups.

NCT ID: NCT04898751 Completed - Clinical trials for Cutaneous Toxicity From ICI Therapy

Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors

Start date: January 1, 2008
Phase:
Study type: Observational [Patient Registry]

Immune checkpoint inhibitors (ICIs) are associated with a wide variety of cutaneous immune-related adverse events (cirAEs). These cirAEs are reported to be the most common immune-related adverse events (irAEs) and the first to appear. This study examines the appearance of cirAEs within the World Health Organization (WHO) pharmacovigilance database, VigiBase.